GPS News  
EPIDEMICS
Brazil set to test Chinese coronavirus vaccine
by Staff Writers
Sao Paulo (AFP) July 21, 2020

Brazil will begin advanced clinical testing of a Chinese-made vaccine against the new coronavirus Tuesday, issuing the first doses to around 900 volunteers, officials said.

The coronavirus vaccine, developed by private Chinese pharmaceutical firm Sinovac, is the third in the world to enter Phase 3 trials, or large-scale testing on humans -- the last step before regulatory approval.

It will be administered to doctors and other health workers who volunteer for the program across six states in Brazil, one of the countries hit hardest by the pandemic.

"Trials of CoronaVac, one of the vaccines that has advanced furthest in testing in the world, will begin at the Clinical Hospital of Sao Paulo," the state's governor, Joao Doria, told a news conference.

He said initial results were expected within 90 days.

Sinovac is partnering with a Brazilian public health research center, the Butantan Institute, on the trials.

If the vaccine proves safe and effective, the institute will have the right to produce 120 million doses under the deal, according to officials.

"In Brazil, we could have the first vaccine to be put to widespread use, which is very, very promising," said the head of the Butantan Institute, Dimas Covas.

Brazil is the second-hardest-hit country in the coronavirus pandemic, after the United States.

Its death toll surpassed 80,000 on Monday, and it has registered 2.1 million infections.

Those grim figures make it an ideal testing ground for potential vaccines, since the virus is still spreading quickly.

Brazil is also helping carry out Phase 3 testing of another experimental vaccine, developed by Oxford University in Britain and pharmaceutical firm AstraZeneca.

Another vaccine, developed by state-owned Chinese company Sinopharm, also entered Phase 3 trials this month in the United Arab Emirates.

They are the three most advanced of the dozens of projects worldwide by scientists racing to develop and test a vaccine against the new virus.

A fourth, existing vaccine against tuberculosis is also in Phase 3 trials in Australia as a potential coronavirus immunization.

val/jhb/to

ASTRAZENECA


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Millions face new virus curbs, but hope rises for US vaccine
Hong Kong (AFP) July 15, 2020
Millions of people faced new coronavirus restrictions on Wednesday as infections surge, but in one sign of hope, an American firm said it would soon start final-stage human trials for a possible vaccine. Countries around the world re-imposed lockdowns and curbs to contain new outbreaks, as global cases surged past 13.2 million with more than 576,000 deaths. Parts of the Asia-Pacific region, which had been somewhat successful in fighting the pandemic, provided fresh evidence of the deadly threat ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Burger King unveils Whopper from cows on green diet

Brazil exports to EU produced on illegally cleared land: report

G20 carbon 'food-print' highest in meat-loving nations: report

Pandemic has silver lining for Iraq: food self-sufficiency

EPIDEMICS
Scaling up the quantum chip

Magnetic memory states go exponential

Dutch chip tech maker ASML resists virus to post growth

DARPA Selects Teams to Increase Security of Semiconductor Supply Chain

EPIDEMICS
Cathay Pacific warns of US$1.3 bn loss in first half

Giant 4G Balloons Illuminate Kenyan Skies With Internet Access

Boeing completes delivery of 37 helicopters to India's air force

US approves sale of 105 F-35 stealth fighters to Japan

EPIDEMICS
Musk says Tesla close to developing fully autonomous car

Bikes wedge their way into heavy Paris traffic

Long road ahead for fully self-driving cars, despite Tesla claim

Volkswagen can be sued anywhere in the EU, says top court

EPIDEMICS
The environmental inbalance of trade

Asian markets mostly up on vaccine, stimulus hopes

Trump ends Hong Kong trade preferences, backs banking sanctions

Asian markets hit by new lockdowns, fresh China-US tensions

EPIDEMICS
Brazil's Bolsonaro under pressure to protect Amazon

Amazon deforestation increases 25 percent in Brazil

Investors want 'results' on deforestation: Brazil VP

French shipping giant to stop Gambian timber exports over smuggling fears

EPIDEMICS
Fallout from COVID-19 pandemic making weather forecasts less accurate

Methane emissions rise nine percent in decade

UP42 Adds exactEarth Ship Tracking Data to Geospatial Marketplace

Proba-V passes the torch

EPIDEMICS
The smallest motor in the world

Crystalline 'nanobrush' clears way to advanced energy and information tech

Transporting energy through a single molecular nanowire

To make an atom-sized machine, you need a quantum mechanic









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.